Report Detail
Global (United States, European Union and China) Parkinson’s Disease Therapeutics Market Research Report 2019-2025
- RnM3689601 |
- 22 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors.
In 2019, the market size of Parkinson’s Disease Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Parkinson’s Disease Therapeutics.
This report studies the global market size of Parkinson’s Disease Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Parkinson’s Disease Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Market Segment by Product Type
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segment by Application
Hospitals
Clinics
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Parkinson’s Disease Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Parkinson’s Disease Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Parkinson’s Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Oral
- 1.3.3 Transdermal
- 1.3.4 Subcutaneous
- 1.3.5 Intestinal Infusion
- 1.4 Market Segment by Application
- 1.4.1 Global Parkinson’s Disease Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Parkinson’s Disease Therapeutics Market Size
- 2.1.1 Global Parkinson’s Disease Therapeutics Revenue 2014-2025
- 2.1.2 Global Parkinson’s Disease Therapeutics Sales 2014-2025
- 2.2 Parkinson’s Disease Therapeutics Growth Rate by Regions
- 2.2.1 Global Parkinson’s Disease Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Parkinson’s Disease Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Parkinson’s Disease Therapeutics Sales by Manufacturers
- 3.1.1 Parkinson’s Disease Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Parkinson’s Disease Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Parkinson’s Disease Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Parkinson’s Disease Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Parkinson’s Disease Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Parkinson’s Disease Therapeutics Market
- 3.6 Key Manufacturers Parkinson’s Disease Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Oral Sales and Revenue (2014-2019)
- 4.1.2 Transdermal Sales and Revenue (2014-2019)
- 4.1.3 Subcutaneous Sales and Revenue (2014-2019)
- 4.1.4 Intestinal Infusion Sales and Revenue (2014-2019)
- 4.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Type
- 4.3 Global Parkinson’s Disease Therapeutics Revenue Market Share by Type
- 4.4 Parkinson’s Disease Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Parkinson’s Disease Therapeutics Sales by Application
6 United States
- 6.1 United States Parkinson’s Disease Therapeutics Breakdown Data by Company
- 6.2 United States Parkinson’s Disease Therapeutics Breakdown Data by Type
- 6.3 United States Parkinson’s Disease Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Parkinson’s Disease Therapeutics Breakdown Data by Company
- 7.2 European Union Parkinson’s Disease Therapeutics Breakdown Data by Type
- 7.3 European Union Parkinson’s Disease Therapeutics Breakdown Data by Application
8 China
- 8.1 China Parkinson’s Disease Therapeutics Breakdown Data by Company
- 8.2 China Parkinson’s Disease Therapeutics Breakdown Data by Type
- 8.3 China Parkinson’s Disease Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Parkinson’s Disease Therapeutics Breakdown Data by Company
- 9.2 Rest of World Parkinson’s Disease Therapeutics Breakdown Data by Type
- 9.3 Rest of World Parkinson’s Disease Therapeutics Breakdown Data by Application
- 9.4 Rest of World Parkinson’s Disease Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Parkinson’s Disease Therapeutics Sales by Countries
- 9.4.2 Rest of World Parkinson’s Disease Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Abbvie
- 10.1.1 Abbvie Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.1.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.1.5 Abbvie Recent Development
- 10.2 Biogen
- 10.2.1 Biogen Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.2.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.2.5 Biogen Recent Development
- 10.3 Boehringer Ingelheim GmbH
- 10.3.1 Boehringer Ingelheim GmbH Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.3.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.3.5 Boehringer Ingelheim GmbH Recent Development
- 10.4 F. Hoffman-La Roche
- 10.4.1 F. Hoffman-La Roche Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.4.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.4.5 F. Hoffman-La Roche Recent Development
- 10.5 GlaxoSmithKline
- 10.5.1 GlaxoSmithKline Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.5.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.5.5 GlaxoSmithKline Recent Development
- 10.6 H. Lundbeck A/S
- 10.6.1 H. Lundbeck A/S Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.6.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.6.5 H. Lundbeck A/S Recent Development
- 10.7 Impax Labs
- 10.7.1 Impax Labs Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.7.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.7.5 Impax Labs Recent Development
- 10.8 Newron Pharmaceuticals SpA
- 10.8.1 Newron Pharmaceuticals SpA Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.8.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.8.5 Newron Pharmaceuticals SpA Recent Development
- 10.9 Novartis AG
- 10.9.1 Novartis AG Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.9.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.9.5 Novartis AG Recent Development
- 10.10 Orion Corporation
- 10.10.1 Orion Corporation Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Parkinson’s Disease Therapeutics
- 10.10.4 Parkinson’s Disease Therapeutics Product Introduction
- 10.10.5 Orion Corporation Recent Development
- 10.11 Teva Pharmaceutical Industries Ltd.
- 10.12 UCB S.A.
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Parkinson’s Disease Therapeutics Sales Channels
- 11.2.2 Parkinson’s Disease Therapeutics Distributors
- 11.3 Parkinson’s Disease Therapeutics Customers
12 Market Forecast
- 12.1 Global Parkinson’s Disease Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Parkinson’s Disease Therapeutics Sales Forecast by Type
- 12.3 Global Parkinson’s Disease Therapeutics Sales Forecast by Application
- 12.4 Parkinson’s Disease Therapeutics Forecast by Regions
- 12.4.1 Global Parkinson’s Disease Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Parkinson’s Disease Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Parkinson’s Disease Therapeutics. Industry analysis & Market Report on Parkinson’s Disease Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Parkinson’s Disease Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Parkinson’s Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
